2016 Flashcards
Secretion of aldosterone is primarily mediated by:
- ACTH
- renin
- serum potassium level
- sodium concentration in the proximal tubule
- sodium concentration in the collecting duct.
2
ACTH and serum potassium may increase aldosterone secretion but the effect is much less pronounced than that achieved by renin . The primary echanism for control of aldosterone production resides in a feedback system involving the kidney and its juxtaglomerular apparatus. In the presence of ppropriate stimuli (i.e., decreased renal perfusion pressure), juxtaglomerular cells release renin which results in the increased production of angiotensin II . ngiotensin II is a potent stimUlator of aldosterone output from the zona glomerulosa of the adrenal cortex. Sodium concentration in the thick ascending Loop of enle (not the proximal tubule or collecting duct) an also be sensed by the macula densa which can stimulate the re lease of renin.
A 55-year-old man undergoes a left lower pole partial nephrectomy for a 3.5 cm solid renal mass. The contralateral kidney is normal. Two days postoperatively, his serum hematocrit drops from 32% to 28% over 24 hours. Urine is dark burgundy in color. Vital signs are stable. The next step is:
- angiography and embolization of bleeding vessels
- reoperation with suture ligation of bleeding vessels
- reoperation with nephrectomy
- bed rest, serial monitoring, and transfusions as needed
- ureteral stent placement.
4
Complications of partial nephrectomy include hemorrhage, urinary fistu la formation , ureteral obstruction, renal insufficiency, and infection. Significant intraoperative bleeding can occur in patients who are undergoing partial nephrectomy. The need for early control and ready access to the renal artery is emphasized . Postoperative hemorrhage may be self-limiting if confined to the retroperitoneum with or without associated gross hematuria. The initial management of postoperative hemorrhage is expectant with bed rest, serial hemoglobin and hematocrit determinations, frequent monitoring of vital signs, and blood transfusions as needed. Angiography may be helpful if bleeding persists, to localize actively bleeding segmental arteries, which may be controlled by angioinfarction. Severe intractable hemorrhage may necessitate re-exploration with early control of the renal vessels and ligation of the active bleeding points. Ureteral stent is not indicated.
Five years after a radical cystectomy and ileal conduit for bladder cancer, a 65-year old man has a serum creatinine of 3.0 mg/di, BUN 40 mg/di, sodium 146 mEq/I, potassium 4.6 mEq/I, and bicarbonate 16 mEq/I. A loopogram shows a 35 cm long moderately dilated conduit with grade 4 reflux into dilated upper tracts. The most appropriate treatment is:
- sodium citrate
- injection of bulking agent into the ureteroenteric anastomosis
- revision of conduit length and stoma
- excision of ileal conduit and conversion to a non-refluxing colon conduit
- bilateral nephrectomies and placement on transplant list.
3
Despite improvement in surgical techniques, stomal stenosis is still the most likely cause of the elongated dilated conduit with hydronephrosis and hyperchloremic acidosis. Therefore, the most appropriate treatment is revision of the stoma and shortening of the conduit. Administration of electrolytes is symptomatic treatment only and does. ot addres th.e anatomic cause of the acidosis. Conversion to a non-refluxing colon.conduit 1s not rqired 1.n this setting where a simpler procedure, shortening of the ileal cndu1t and. stom I rev1s1on, .w l suffice. Treatment of high grade vesicoureteral reflux by a bulking agent in a 1leal conduit is not indicated· the high grade reflux is a direct sign of distal obstruction and 1s usually due tc either stomal or mid-ileal loop stenosis. Although this patient may event lly need a ren transplant, a functional loop is necessary for transplantat on, tereore, rev1s1on of the loop 1 indicated. No indications are currently present for proceeding with bilateral nephrectomy.
A seven-year-old, neurologically normal boy with recurrent UTls and worsening diurnal incontinence has a normal renal ultrasound and VCUG. His bowel function is normal. Urodynamic evaluation reveals detrusor overactivity and increased sphincter activity during voiding. His initial treatment should be
- maintenance of voiding diary and timed voiding
- biofeedback
- pelvic floor muscle retraining
- oxybutynin
- prazosin
1
Dysfunctional voiding syndrome is frequently manifested by worsening diurnal incontinence posturing when voiding, with or without primary nocturnal enuresis, recu:re.nt UTls, anc encopresis. Classically , urodynamic studies will reveal poor cerebral appreciation of sudden detrusor contractions. Voluntary sphincter contraction 1s thought to be a reponse to udder detrusor contraction. This can arise from either delayed neurourlogic .maturation o inappropriately learned voiding behavior. Initial treatment should be with maintenance of voiding and stooling diary , timed voiding every two hours while awake, and treatment of constipation issues if present. Approximately 80-85% of patients will resolve their symptoms o this treatment. Individuals failing the conservative management outlined above may be treat by either the addition of antimuscarinics, such as .oybutynin or alternatively, behavioral modification with biofeedback pelvic floor muscle retraining. Use of a sacral nuromodulatc should only be considered after the patient has failed the mar conseat1ve treamer modalities outlined above. Prazosin, an alpha-1- receptor blocker, 1s potentially useful in thsetting of bladder neck dysfunction but not in the patient described above.
Two grams of oral ascorbic acid (Vitamin C) per day will:
- decrease urinary calcium
- increase urinary oxalate
- decrease urinary magnesium
- decrease urinary acidity
- decrease urinary citrate
2
Approximately 10-20% of dietary ascorbate is metablized into oxalic a.cid that is ten excret into the urine. Ascorbic acid in doses of 2 grams daily was shown to increase urinary oxala by 20-30%, but had no effect on urinary pH, citrate, calcium, or magnesium.
A one-month-old girl with prenatal hydronephrosis underwent postnatal imaging as shown. The most likely cause of findings in the bladder and kidney is:
- VUR
- UPJ obstruction
- ureterocele
- bladder diverticulum
- ectopic ureteral insertion into the vagina.
3
Ureteral duplicaion is one of the most common renal abnormalities with approximately 1% of the population diagnosed as having a duplication anomaly during their lifetime with 10% of the affected indiiduals ill have a bilatral duplicatio anomaly. In individuals with a duplication anmaly, 10 Yo are diagnosed following an evaluation for a UTI, another 10% are discovered dnng an evluatio for p:enatal h.ydronephrosis , and the remainders are incidentally d1s ove:ed during rad1ograph1c evaluations. Severe upper pole hydronephrosis of a duplicated moiety 1s com?nly associated with either a ureterocele or ureteral ectopy, while lower pole hyronephros1s 1s common ly associated with vesicouretera l reflux or a UPJ obstruction. In this patient, the ulrasoud. (US) images are classic for obstruction of the upper pole due to a ureterocele. D1fferent1at1on of a ureterocele from an ectop ic ureter can at times be problematic. Indeed, te term “pseudourete:ocele” has been coined for enlarged ectopic ureter that protrudes into the bladder. Classically , a tip off that it is an ectopic ureter and not a ureterocele is found in the thickness of the ureterocele membrane. Presence of a thin-wall membrane is almost invariably associated with a ureterocele. In contrast, a thick-walled “ureterocele” or cystic structure may indicate a ectopic ureter with the thick wall being attenuated detrusor muscle. Inadvertent endoscopic incision of a pseudoureteroce le has led to the creation of detrusor-ureteral-vaginal f istulas that may be highly problematic to repair in a neonate. To differentiate. an ectoic uretr (pseudoureterocele) from a ureterocele, a VCUG may be helpful. If the ectopic reer insert into t.he bladder neck or urethra, reflux into the upper system may be faun? confirming the d1agnos1s of an ectopic ureter. If no reflux is noted and the physician has a high degree of suspicion that the diagnosis is truly an ectopic ureter, a pelvic MRI or CT scan may be of benefit.
A newborn girl had moderate left hydroureteronephrosis on prenatal ultrasound. Ultrasound at one month of age demonstrates normal kidneys bilaterally. Physical examination is normal. The next step is
- observation
- VCUG
- MAG-3 renal scan
- repeat ultrasound in three months
- MR urogram.
2
It is not uncommon for children with prenatally recognized hydronephrosis to have normal renal. ultrsou.nd after bi · Man of these represent patients with insignificant prenatal phys1olog1c d1lat1on. Spec1f1cally , in patients with a history of mild to moderate fetal hydronephro!s and a noral postnatal ultrasound , the latter obtained one to two months post art.um; add1t1onal evaluations are deemed unnecessary . The exception to this rule is the f1nd1ng of moderate to severe hydroureteronephrosis found on the prenatal evaluation with a normal post-partum ultrasound. The presence of ureteral dilation on the prenatal ultrasound has been ound to be associated.with a significant increased risk for neonatal UTls and high grade ves 1coureteral reflux despite a normal postpartal renal ultrasound. Documentation of ureteral dilation on the fetal ultrasound, therefore , results in the recommendation that a neonatal VCUG be obtained. Observation alone may miss the opportunity to diagnose high grade VUR and place this infant at significant risk. Repeat ultrasound at such a short interval is not indicated and, if normal, would not obviate the need for a VCUG. MAG-3 renal scan should be considered if the neonatal follow-up ultrasound evaluations demonstrate perslstenl hydroureteronephrosis and the VCUG reveals absence of reflux .. Antibiotic prophylaxIs IS recommended for infants found on neonatal ultrasound to have a dilated ureter and/or VUR. Unless the renal ultrasound reveals a structural abnormality, i.e ., poorly defined duplication anomaly, magnetic resonance urogram would not be indicated. Serial observation without the need for antibiotic prophylaxis would be indicated in the presence of hydronephrosIs alone without evidence of prenatal ureteral dilation. In these latter infants, a MAG-3 renal scan with a diuretic washout phase wou ld be indicated at two to three months of age.
A 16-year-old boy passes a stone composed of 100% cystine. This condition is characterized by:
- excessive jejunal absorption of cystine
- excessive tubular resorption of arginine and lysine
- inadequate tubular resorption of ornithine and cystine
- excessive metabolic production of cystine, ornithine and lysine
- impaired conversion of cystine to ornithine.
3
Cystinuria is the result of inadequate renal tubular resorption of cystine, ornithine, lysine, arginine, and is also associated with inadequate intestinal absorption of these amino acids. Stones result from increased concentrations of cystine in the urine which precIpitate In aCldl1 urine. The other amino acids do not crystallize to form stones.
A 42-year-old infertile man has a semen volume of 2 ml, sperm density of 5 million/ml, and decreased sperm motility. Physical examination demonstrates a grade 3 left varicoce le and grade 1 right varicocele. His partner’s evaluation is normal. The next step is
- transrectal ultrasonography
- clomiphene citrate (Clomid™)
- intrauterine insemination
- left varicocelectomy
- bilateral varicocelectomy.
5
Semen parameters improve to a greater extent after bilateral varicocelectomy as compared to just repairing the dominant varicocele in patients with a grade .’I-III varicoele and contralateral grade I varicocele. This approach does not extend to patients with a subclinical varicocele (those only detected by Doppler ultrasound). Transrectal ultrasonography all clomiphene citrate (Clomid) are not indicated in this setting. Intrauterine insemination ~another alternative but varicocelectomy is more cost effective. Intrauterine Insemination is not indicated because sperm concentration is too low. Age of the female partner is also an important consideration ; if partner is older, in vitro fertilization should be considered as treatment option.
A 14-year-old boy with myelodysplasia and a ventriculo-peritoneal shunt has acute abdominal pain. He underwent a sigmoid bladder augmentation six months ago. His pulse is 100 bpm and blood pressure is 100/70 mmHg. He has diffuse abdominal tenderness . Urine output over the past six hours is 70 ml. Cystogram shows no extravasation. The best management is l.V. hydration, broad spectrum antibiotics, and:
- abdominal CT scan
- CT cystogram
- continuous catheter drainage
- placement of large-bore (24F), percutaneous suprapubic tube
- exploratory laparotomy .
2
It is noteworthy that up to 50% of cystogram studies in cases of a ruptured augmented bladder may be negative for the injury; therefore, a negative cystogram does not rule out a bladder rupture. With this patient having clear clinical signs of acute peritoneal inflammation the differential diagnosis is . cystitis with peritoneal irritation (treated by antibiotic therapy’ and continuous bladder drainage and not requiring surgery), a loculated infected ventriculoperitoneal shunt (requiring a neurosurgical consultation), or a missed bladder rupture (requiring emergent surgery). Confirmation of suspected perforation of an augmented bladder is best achieved by performing a CT cystogram with a minimum of 300 ml of contrast placed in the bladder with a CT phase taken with the bladder distended and emptied. An abdominal CT without a cystogram may show a significant increase in peritoneal fluid if an infected VP shunt is present (false positive for bladder rupture) or, alternatively, a high false negative rate for rupture if a small bladder perforation is present and occluded by either small bowel or omentum. The performance of a CT cystogram with a minimum of 300 ml of contrast has been shown to dislodge the omentum or small bowel that would be plugging the bladder laceration and diagnosis of extravasated contrast is more readily found on the CT evaluation than the plain cystogram. Placement of a large bore suprapubic tube will not sufficiently divert urine or drain infected urine from the peritoneal cavity if a bladder rupture is present. Continuous catheter drainage along with I.V. antibiotics may be of benefit for severe cystitis but should only be pursued after documentation of the absence of a bladder perforation. Exploratory laparotomy would be indicated without a CT cystogram if the patient was clinically unstable and not responsive to fluid resuscitation.
A 26-year-old man has bilateral gynecomastia . Testicular examination is normal. Free testosterone is elevated and LH is decreased. The next step is:
- cranial MRI scan
- abdominal CT scan
- testicular ultrasound
- serum prolactin
- serum estradiol.
3
Gynecomastia occurs in the male when there is an alteration of the testosterone-estradiol ratio which may be due to either reduced testosterone or elevated estradiol . The ddx of gynecomastia in an adult includes prolactin-secreting pituitary tumor, estrogenic drugs, exogenous testosterone, testicular tumors, and idiopathic. The elevated testosterone level with low gonadotropin levels in this patient is most suggestive of either exogenous testosterone or a testicular tumor. Exogenous testosterone will usually result in a reduction in the size and softening of the consistency of the testes. The most likely etiology is a testicular tumor despite his normal testicular physical examination. Leydig cell tumors are one of the more common non pa lpable testicular tumors and with their inherent abi lity to secret testosterone is the most likely diagnosis. If it had been a prolactin secreting tumor, the LH and the testosterone would be low. The MRI scan is not needed since the pituitary is responding normally and prolactinoma is not suspected. Gynecomastia in these patients is caused by the conversion of excess (unregulated) testosterone to estradiol by aromatase.
The characteristic that distinguishes primary hypoadrenalism from secondary (pituitary) hypoadrenalism is:
- hypotension
- metabolic alkalosis
- cutaneous hyperpigmentation
- hypernatremia
- hypokalemia.
3
Since the amino acids of ACTH are identical to the terminal amino acids of melanocyte stimulating hormone (MSH), over-production of ACTH results in cutaneous hyperpigmentation. Adrenal loss results in lack of negative feedback and over-production of ACTH. Pituitary failure , on the other hand, results in a lack of ACTH. Vitiligo may also be seen in these patients. Primary hypoadrenalism (or Addison’s disease) is notable for hyponatremia (not hypernatremia) and hyperkalemia (not hypokalemia). Hypotension can be present In primary or secondary hypoadrenalism.
A two-year-old girl has a large abdominal mass. Chest and abdominal CT scans show clear lung fields with a 12 cm tumor arising from the center of the right kidney and two 3 cm exophytic tumors of the mid- and lower poles of the left kidney. The next step is:
- initiate chemotherapy
- bilateral percutaneous needle biopsy
- exploration and bilateral open renal biopsy
- right nephrectomy and partial left nephrectomy
- bilateral nephrectomy.
1
There is a high probability that this two-year-old girl has bilateral Wilms: tumor. The current Children’s Oncology Group Wilms’ Tumor protocol recommends 6 weeks of chemotherapy without the need for renal biopsy in patients with highly probable bilateral Wilms’ tumor. The response to the chemotherapy is assessed after six weeks of chemotherapy by CT or MRI scans. Imaging at this time will quantify any reduction in tumor volume and allow the surgeon to assess the feasibility of renal sparing surgery. Tumors responding to chemotherapy may receive a second round of medications in an attempt to further reduce the size of the tumor allowing the surgeon to maximally salvage non-involved renal parenchyma. Tumors not responding to therapy will require bilateral open renal biopsy and lymph node sampling in order to both determine histopathology and guide further treatment. Although right nephrectomy and partial left nephrectomy may eventually be the ultimate outcome for this patient, chemotherapy is the initial step in management with renal preservation the primary goal.
During a laparoscopic donor nephrectomy, a 2 cm laceration is made in the splenic flexure of the colon. The most appropriate action is to:
- abandon the operation
- close the laceration , administer broad-spectrum antibiotics to the donor and continue with the transplantation
- close the laceration, irrigate wound with neomycin, and proceed with the transplantation
- close the laceration, administer broad-spectrum intravenous antibiotics to the donor and recipient , and proceed with the transplantation
- close the laceration, irrigate wound with neomycin, administer broad-spectrum ant1b1ot1c to the donor and recipient, and proceed with the transplantation.
1
Infection transmitted from a cadaver donor to an immunocompromised recipient can be rapidly fatal. Gross bacterial contamination of the operative site gives the surgeon only one single safe option which is to abandon the procedure.
A 24-year-old man is shot in the right flank and sustains a grade 5 renal injury and extensive liver and bowel injury. During exploration, his liver and bowel injuries are stabilized and a nonpulsatile right retroperitoneal hematoma is identified with no intervention . One week after exploration, he develops increased drainage from a perihepatic drain. Creatinine of the drainage fluid is 8 mg/di. CT scan and retrogradepyelogram are shown. The next step is:
- ureteral stent
- ureteral stent and urethral catheter
- percutaneous nephrostomy
- exploration, debridement, and renal repair
- nephrectomy.
2
The patient has a delayed urine leak following high velocity penetrating renal trauma. CT scan and retrograde pyelogram reveal a urine leak. The next step is ureteral stent and urethral catheter drainage to prevent reflux of urine retrograde into the stent which may potentiate the leak and result in infection of the retroperitoneal hematoma. Ureteral stent placement may allow for resolution of the leak without operative intervention. The patient’s recent history of shattered kidney along with liver and bowel injury placement of a percutaneous nephrostomy tube would result in increased risk for infection of the perinephric hematoma and maybe difficult to place and maintain in the proper position due to the renal injury. Exploration of the right kidney is not ind icated at this time.
Antenatally diagnosd marked bilateral hydronephrosis is confirmed postnatally in a newborn girl. VCUG 1s normal. The next step is:
- magnetic resonance urogram
- MAG-3 renal scan
- DMSA renal scan
- CT urogram
- repeat ultrasound in two months.
2
In this setting, one must determine if the hydronephrosis is causing significant obstruction and, if so at what level in the urinary tract. The ultrasound may show ureteral dilation which suggests obstruction at the ureterovesical junction, but the MAG-3 renal scan will determine the differential function and the degree of obstruction. The ideal timing for performing this study is during the second month of life when the GFR has increased several fold. DMSA scan would not provide information regarding degree or level of obstruction. The MR urogram may be useful after the first week of life, but does not provide dlfferenlial renal function. Antegrade studies are not needed at this point and should not be performed prior to the less invasive MAG-3 renal scan. CT urogram does not provide quantitative data and exposes the infant to unnecessary radiation and anesthesia.
- Reflex bladder and urethral activity are coordinated by a reflex center located in the:
- sacral cord
- thoracic and sacral cord
- pons
- medulla
- basal ganglia.
3
The center for integration and coordination of bladder and urethral activity is in the pons (pontine micturition center). Suprasacral spinal cord injury disrupts the. necessary communication between the pontine micturition center and the sacral cord. This results In detrusor overactivity and detrusor external sphincter dyssynergia. Patients with this issue may have urinary incontinence, incomplete bladder emptying, and their upper tracts may be at risk.
Nephrocalcinosis of infancy:
- should be treated by thiazide diuretics
- results in a high incidence of renal calculi in childhood
- is associated with distal renal tubular acidosis
- may completely disappear after stopping furosemide
- should be treated by increased calcium and phosphate in the neonatal diet.
4
Nephrocalcinosis of infancy has been found in up to 64% of low birth weight < 1500 g) Dr premature infants (gestational age of 32 weeks or less). Specifically, neonates who require oxygen for greater than four weeks of life, undergo dietary supplementation with high calonc formula (increased calcium and phosphate), and infants receiving loop diuretics are at the highest risk. The largest risk factor for nephrocalcinosis is in infants who have received looP diuretics (furosem ide) to treat fluid overload, improve pulmonary oxygenation, and Increase card iac output. Indeed, 70% of the patients with nephrocalcinosis will have a history of prolonged loop diuretic exposure. The normal hypercalciuric effect of furosemide found In adults is enhanced in infants by the reduced glomerular filtration rate and the decrease hepatic filtration/metabolism function associated with infancy. The reduction in GFR and decreased systemic clearance of loop diuretics by the liver will significantly prolong the half-life of this drug, resulting in excesslve hypercalciuria. In infants with clinically documented nephrocalcinosis, approximately 15% will develop renal calculi by five years of age. The calculi isolated from these patients are composed exclusively of calcium oxalate. The vast majority of these infants (85%) will completely resolve their nephrocalcinosis following stopping the use of loop diuretics. Although neonatologists will frequently replace the use of loop diuretics by using thiazides for fluid management issues in these critically ill infants, it is noteworthy that resolution of nephrocalcinosis has not been found to be significantly enhanced by the use of thiazides. Treatment of. infants diagnosed with nephrocalcinosis should be with stoppage of the loop diuretiCs and Interval follow-up with renal ultrasound until the nephrocalcinosis has resolved or alternatively renal calculi have been documented to develop and necessary treatment has been accomplished. There is no association of nephrocalcinosis of infancy to renal tubular acidosis. Increased dietary calcium and phosphate in the diet routinely found in infant high caloric formula supplements may at times actually
The initial nephrostomy tube puncture site in a horseshoe kidney compared to that in a normally positioned kidney is more:
- medial and through a posterior calyx
- lateral and through an anterior calyx
- medial and through an anterior calyx
- lateral and through a posterior calyx
- inferior and through an anterior calyx.
1
Horseshoe kidneys may develop renal calculi, possibly as a result of high insertion of the ureter and relative stasis of urine. Patients with small, nonobstructing calculi in nondependent locations may be treated with SWL. However, obstructing calculi or those that are large or in dependent locations, are best treated with percutaneous techniques. The initial puncture is more medial than that for normally positioned kidneys and should be placed through a posterior calyx.
A newborn boy has a left-sided abdominal mass. Ultrasound reveals an infiltrative mass replacing the lower third of the left kidney. The right kidney appears to have a slightly increased echogenicity , but is otherwise normal. The next step is:
- bilateral needle biopsy of the kidneys, then chemotherapy
- exploratory laparotomy and bilateral biopsy
- left nephrectomy followed by chemotherapy
- left lower pole partial nephrectomy followed by chemotherapy
- left nephrectomy and surveillance.
5
This disease process is most likely a congenital mesoblastic nephroma (CMN) and should be distinguished from a Wilms’ tumor by the patient’s age and the fact that CMN is typically infiltrative on imaging, whereas Wilms’ tumors displace and compress renal architecture. CMNs are the most common tumor in infants greater than four months of age, with a median age at the time of diagnosis of three months. In contrast, the median age for diagnosis of a Wilms’ tumor is 3.5 years. Two types of mesoblastic nephroma exist, the classic type which is far more common, and, provided surgical margins are negative, rarely recur and the cellular variant. The cellular variant consists of atypical spindle cells with frequent mitotic figures (25-30/10 hpf) and necrosis and is considered a variant of a fibrosarcoma. This. variant is associated with both local recurrence and widespread metastasIs. Surveillance by Interval SIX month abdominal ultrasounds for the first two years is usually recommended for the classIc variant and more aggressive follow-up with interval CT or MRI scans of the lungs and abdomen are recommended at three to six month intervals for the first two years for the cellular variant. Normal newborn kidneys are slightly echogenic, hence, the right kidney is normal in the boy presented here.
The factor most likely to increase the risk of a perirenal hematoma after SWL is:
- hypertension
- stone size > 2 cm
- > 2,000 shocks
- UTI
- diabetes mellitus.
1
Preoperative HTN, especially uncontrolled HTN, and bilateral application of SWL are risk factors for the development of perirenal bleeding. Patient size or weight, or stone size location and number do not correlate with this complication. Clinically significant peri-renal hemtomas occur in approximately 0.2-0.4 % of patients undergoing SWL. Most such patients can be managed with surveillance, although a third may require transfusion.
During transvaginal repair of a high vesicovaginal fistula, a Martius flap is harvested, but is of insufficient length to reach the fistula site. The next step is:
- myocutaneous gracilis flap
- gluteal flap
- omental flap
- peritoneal flap
- myocutaneous labial flap.
4
Uncomplicated vesicovaginal fistulas can be closed using meticulous technique and a multi· layer closure. Repair of more complex fistulae often requires the . use of well-vascularized tissue flaps positioned between the bladder and vaginal repair sites. The use of Martlus (fibrofatty tissue), myocutaneous labial (skin and fibrofatty tissue) or: more rarely, gluteal skin flaps can be used to repair low fistulas. Such flaps may not be of sufficient length to reach high fistulae. Peritoneal flaps can be harvested through the vaginal incision and are In close proximity to such fistulas. Use of peritoneum obviates the morbidity of an abdominal incision (necessary for harvesting the omentum) or an incision along the Inner thigh (necessary for harvesting the gracilis muscle).
A 26-year-man undergoes orchiectomy for seminoma. Abdominal CT scan and tumor markers are negative. He elects surveillance. The most accurate statement regarding his outcome over the next two years is:
- similar risk of relapse as patients treated with XRT
- 5% risk of visceral relapse
- 5% risk of relapse with non-seminomatous elements
- 15% risk of retroperitoneal relapse
- 15% risk of pulmonary relapse.
4
The standard of care for decades in a patient with clinical stage I seminoma (negative CT scan and negative tumor markers) was retroperitoneal XRT. In patients receiving XRT for stage I seminoma, the risk of overall relapse is 5% or less and it would be extremely uncommon for such a patient to relapse with nonseminomatous elements. The major concern regarding the routine use of XRT In these patients was the risk of secondary malignancy, usually leukemias and lymphomas found in approximately 18% of patients 25 years after radiation therapy. To reduce the risk of secondary malignancy, surveillance may be a reasonable option. In a patient with stage one seminoma, there IS an approximately 15% risk of relapse of the tumor to retroperitoneal lymph nodes; almost all are salvaged provided they were reliable candidates for serial surveillance and were not lost to follow-up. Visceral and pulmonary relapse of seminoma or alteration to non-seminomatous elements is extremely uncommon in patients with stage I seminoma. Single agent carboplatln IS the other option in place of either XRT or observation for clinical stage I seminoma and is associated with a 3-5% relapse rate in reported series.
A five-year-old boy has a two-week history of severe daytime urinary frequency . There is no history of UTI and urinalysis is negative. Physical and neurological examination are normal. The next step is voiding diary and:
- reassurance
- oxybutynin
- tamsulosin
- ultrasound
- VCUG.
1
This is a typical presentation of pediatric benign urinary frequency syndrome and is best managed expectantly. Reassurance is all that is necessary with the expectation that the symptoms will resolve in .one to three months. It is important to confirm that both the physical examination and UA are normal with no evidence of neurologic abnormalities such as a spinal dimple or lower extremity weakness or UTls. In most instances, pharmacological therapy and invasive investigation or therapy have proven to be unsuccessful and may actually worsen symptoms. In almost all cases, these symptoms resolve spontaneously within a few months and the family should be reassured.
A 74-year-old man with a Studer ileaI neobladder develops invasive urothelial carcinoma of the proximal urethra three years post-cystectomy. A metastatic evaluation is negative. The next step is:
- BCG instillation in the urethra and neobladder
- urethrectomy and transverse colon loop construction
- urethral laser fulguration
- urethrectomy and continent cutaneous diversion
- urethrectomy and use afferent limb for cutaneous diversion.
5
Urethral recurrence after neobladder is an uncommon but troublesome complication best treated with urethrectomy and some form of urinary diversion. The Studer neobladder affords a reasonable solution to this problem since the non-intussuscepted afferent limb may be detached from the neobladder and converted to a standard ileal loop. A transverse colon conduit would require ureteral reimplantation and continent cutaneous diversion and while an option, would have a greater complication rate in an older and previously operated upon patient. Local therapies, such as BCG and laser ful guration , are inadequate for this invasive tumor.
A 23-year-old woman has dull, persistent, bilateral flank pain. A scout CT image without contrast is shown. Serum calcium is 9.4 mg/di and urine calcium on an unrestricted diet is 300 mg/day (normal < 250 mg/day). Urine culture is negative. The next step is:
- observation
- thiazides
- potassium citrate
- percutaneous nephrolithotomy
- parathyroidectomy.
2
The radiograph demonstrates the typical “bunches of grapes” or “bouquet of flowers” appearance of medullary sponge kidney. The charactenstlc anatomic feature .of medullary sponge kidney is dilation of the distal portion of the collecting ducts associated with numerous cysts and diverticula. If symptomatic, most patients (60%) present with flank pain, followed by UTI (25%) and gross hematuria (15%). For patients with renal lithiaSIS and hypercalcluria, thiazides should be administered as they arrest stone growth and prevent new stone formation. Parathyroidectomy is not indicated in this patient with normal serum calcium and no measurement of serum parathormone. In the absence of an obstructing stone, PCNL IS not indicated.
A 16-year-old phenotypic girl undergoes evaluation for primary amenorrhea. Testes are found on laparoscopic examination. Karyotype is 46 XY. If the gonads are not removed, the tumor most likely to develop is:
- seminoma
- Leydig cell tumor
- gonadoblastoma
- embryonal cell carcinoma
- teratoma.
1
The syndrome of complete androgen insensitivity (CAIS), previously known as testicular feminization syndrome is due to absence of a functional androgen receptor. All affected individuals will have a 46 XY genotype and approximately 80% will have “normal” appearing external female genitalia. These patients currently present by one of five different means: fe tal karyotype (46 XY) incongruent with newborn infant’s phenotype (5% of patients), relative or family member with CAIS with patient diagnosed due to recommendation for genetic screening (15% of patients), ambiguous genitalia at bIrth, i.e. , female phenotype with ralpablegonads or mild to moderate clitorimegaly (20% of patients), primary amenorrhea 0 (30 Yo of patients),. and testicle found within a inguinal hernia at the time of surgical repair (30 Yo. of patients). Patients with complete androgen insensitivity syndrome will have a substantial Increased risk of developing a testicular seminoma and if the testis is left in situ , approximately 20% of the patients will have developed a testicular malignancy by the age of 30. Removal of the testicles are, therefore, strongly recommended either prior to or Immediately following pubescence. Gonadoblastoma is a tumor that is associated with disorders of sex development. Specifically, it is found in infants noted to have partial or pure gonadal dysgenesis (46 XY or 46 .XY/XO genotypes) and is not associated with complete androgen insensitivity syndrome. IndiVidualswith complete androgen insensitivity syndrome are at no higher risk of Leydig cell tumors, embryonal cell carcinoma, and teratomas than the normal population.
A 36-year-old man with ejaculatory duct obstruction and a left varicocele has persistent azoospermia despite normalization of ejaculatory volume following TUR of the ejaculatory duct. The next step is: TRUS 2. repeat TUR of the ejaculatory duct 3. scrotal exploration and testis biopsy 4. varicocelectomy 5. donor insemination.
3
Persistent azoospermia following resection of the ejaculatory ducts may be due to persistent obstruction, concomitant epididymal obstruction, or testicu lar failure. The restoration of normal ejaculate volume rules out persistent ejaculatory duct obstruction, therefore, neither a repeat TUR-ejaculatory duct nor a TRUS is indicated. Scrotal exploration is necessary to differentiate between epididymal obstruction and testicular fa ilure. Donor insemination is not necessary with obstructive azoospermia unless the obstru ction is uncorrectable and the couple refuses ICSI. Varicocelectomy may be indicated in some instances of non-obstructive azoospermia but it is not helpful with obstructive azoospermia.
A 17-month-old boy has a firm, smooth testicular mass. Testicular ultrasound shows a2 cm upper pole intratesticular cyst with preservation of the parenchyma. Tumor markers are negative. The next step is:
- transscrotal enucleation
- radical inguinal orchiectomy
- inguinal exploration with cyst enucleation
- cyst aspiration for cytology
- simple orchiectomy with placement of prosthesis.
3
The differential diagnosis of cystic testicular lesions includes: epidermoid cyst, dermoid cyst, prepubertal te ratoma, Juvenile granulosa ce ll tumor, cystic dysplasia of the rete testis lymphangioma, simple cyst, and cyst degeneration after torsion. The patient’s age, physical examination, and ultrasound findings suggest an epidermoid cyst or simple cyst. Since these lesions are clinica lly indistinguishable from neoplasms, preoperative tumor markers should be drawn. In this age group, if preoperative tumor markers are negative and a benign lesion is suspected on imaging, testiCUlar sparing surgery via an ingu inal incision with the use of frozen section histopathology for confirmation, should be attempted when possible. Cyst aspiration for cytopathology IS neither diagnostic nor ind icated, and worst, would upstage a malignant tumor and potentially seed the needle tract. Placement of a prosthesis is usually delayed until adolescence when an appropriate size prosthesis can be used, as well as involve the adolescent or young adult patient in preoperative discussion as to thei r desire for a prosthesis.
A three-year-old boy has a 48-hour history of abdominal pain, fever, vomiting, bloody diarrhea, hematuria, and oliguria. Physical examination reveals mild peripheral edema. Laboratory evaluation demonstrates hemoglobin of 5 g/dl, thrombocytopenia, and serum creatinine of 3.2 mg/di. The most likely etiology is infection caused by:
- streptococcus
- E. coli
- cytomegalovirus
- Clostridium difficile
- hepatitis C virus.
2
This patient has hemolytic uremic syndrome. This is most frequently due to E. coli infection, 70% due to the 0157:H7 serotype. In recent years, many large outbreaks have occurred due to eating uncooked hamburger meat, cheese made from unpasteurized dairy products,. and unpasteurized apple cider. With aggressive management of the acute renal failure, the majority of patients will recover normal renal function. The presentation IS classIc, with a prodrome of enterocolitis with bloody diarrhea, fever, gross hematuria , and oligurlc renal failure. Treatment is supportive. Although hemolytic uremic syndrome classically arises following an E. coli enterocolitis, it can develop as a consequence of streptococcus pneumonia, post-bone marrow transplant, and Vitamin B12 metabolic disorders.
A 35-year-old man has persistent retroperitoneal lymphadenopathy after platin-based chemotherapy for NSGCT. The parameter most predictive of finding only fibrosis in the retroperitoneum is:
- pre-chemotherapy lymph node size
- 75% reduction in size of the mass on CT scan
- pure embryonal cell carcinoma in the primary tumor
- pre-chemotherapy marker levels
- teratoma in the primary tumor.
3
Patients with fibrosis/necrosis, only in the post-chemotherapy specimens, have a favorable prognosis with relapse rates of 10% or less in most series. Investigators have sought to identify factors that reliably predict for a high probability of fibrOSis/necrosIs In a postchemotherapy residual mass. The absence of teratoma in the primary tumor, the percentage reduction in the retroperitoneal mass with chemotherapy (usually cited as 90% or greater), and the size of the post-chemotherapy residual mass have consistently been identified as predictors of fibrosis/necrosis in the post-chemotherapy specimens. In this question, pure embryonal carcinoma would be the best predictor of fibrosis only in the retroperltoneum. Neither pre-chemotherapy lymph node size nor pre-chemotherapy serum tumor marker levels are predictive for fibrosis and the percent reduction has been cited as 90% or greater to predict fibrosis. The absence of teratoma in the primary would predict for fibrosis, not the presence of teratoma.
A ten-year-old boy with acute lymphoblastic leukemia has right flank pain, nausea, and vomiting after chemotherapy. Urinalysis shows pH 5.5, 10-20 RBC/hpf, and 5-10 WBC/hpf, platelet count is 50,000/cu mm, and WBC is 3,500/cu mm. Ultrasound images are shown. The next step is:
- observation and antibiotics
- urine alkalinization
- SWL
- percutaneous nephrostomy
- ureteral stent.
5
This child has an obstructing lower ureteral calculus. His immune status is depressed due to his recent chemotherapy, including a low platelet and WBC count. He is symptomatic and requires decompression of his kidney before he becomes septic. Considering his hematologic state, the best option is ureteral stent placement. Although observation, antibiotiCS, and/or alkalinization with a distal uric acid stone may be appropriate in an asymptomatic patient, In this scenario immediate decompression is necessary. Ureteral stent is a better option than percutaneous nephrostomy due to the thrombocytopenia. SWL is not appropriate for a distal ureteral stone in a child.
A 42-year-old man had a right radical nephrectomy two yers ago for a _stage pT3aNOMx RCC. He now has right hip pain. Bone scan shows intnse _uptake in the right hip area and plain films of the right femur show a 3.5 cm lyt1c lesion. The next step is:
- external beam radiation to the femur
- strontium-89
- internal fixation of the femur
- pain management
- systemic targeted therapy.
3 Approximately 50% of patients with multi-organ metastases from RCC exhibit evidence of skeletal Involvement. It has been estimated that between 15% and 30% of such skeletal lesions are solitary. Eighty percent of skeletal metastases occur in the axial skeleton, thoraCic/lumbar spine, and pelvIs. When long bones are involved, only the proximal portions are characteristic targets for metastatic disease. Surgical treatment of bony metastases is ind icated for weight-bearing bones with lytic lesions > 3 cm. Internal stabilization or replacement of the destroyed periarticular segment often results in significant pain relief and tremendously Improves the patient’s quality of life. For a lesion this large, XRT or strontium are likely to be Ineffective. This patient needs surgery to prevent fracture as a priority over systematic treatments or pain management alone
A three-year-old boy with thoracolumbar myelomeningocele has diurnal and nocturnal urinary incontinence. Renal ultrasound is normal and VCUG shows no VUR. Urodynamic study reveals total fill noncompliance with end-fill detrusor pressures of 50 cm H20 at 150 ml. In addition to the poor compliance, there is intermittent detrusor overactivity beginning at 50 ml, with intermittent urge incontinence noted to be associated with the overactivity. Tonic external sphincter activity is noted with the leakage. The next step is:
- timed voiding
- antimuscarinics
- antimuscarinics and CIC
- onabotylinumtoxinA to the external urinary sphincter
- onabotylinumtoxinA into the detrusor muscle and CIC.
3
This boy has findings consistent with a neurogenic bladder associated with high storage pressures, detrusor overactlvlty, and tonic sphincter activity. In this scenario, if the physician is seeking to gain both urinary continence and provide safe storage pressures, treatment of the detrusor to Improve compliance, decrease overactivity, and CIC to empty the bladder must be the mainstay of treatment. Injection of onabotulinumtoxinA into the external urinary sphincter would decrease detrusor LPP but would not aid in urinary continence. Although the combination of onabotulinumtoxinA into the detrusor and CIC would work, this would require general. anestheSia to accomplish In a pediatric-aged patient and should not be pursued unless the patient has failed more conservative measures such as oral antimuscarinics and CIC. Enterocystoplasty could be considered as an option if medical therapy fails.
During laparoscopic left radical nephrectomy, jud icious placement of clips on the primary branches of the main renal vein is most important to facilitate:
- lymphadenectomy
- en bloc excision with negative margins
- adrenalectomy
- application of the endovascular stapler onto the main renal vein
- dissection and occlusion of the main renal artery(ies).
4
Excessive placement of clips when managing the gonadal, adrenal, or lumbar branches can severely restrict the working space available for safe placement of the endovascular stapler later in the case when the main renal vein is addressed. Application of the stapler across a clip can lead to intraoperative or postoperative hemorrhage and must be avoided. Use of clips should have no effect on the ability to perform the lymphadenectomy, adrenalectomy, or the ability to achieve negative margins, or ability to control renal artery.
- During laparoscopic live donor nephrectomy, the kidney becomes visibly pale with loss of turgor after 15 minutes of hilar dissection. The next step is:
- reduce insufflation pressure
- fluid bolus
- intraarterial papaverine
- systemic heparin
- convert to open nephrectomy.
1
Renal artery vasospasm may occur during renal hilar dissection, leading to reduced renal perfusion. The first step shou ld be to simply reduce the insufflation pressure. This maneuver will allow improved renal perfusion and no additional steps are necessary in the majority of patients. If renal perfusion continued to be suboptimal, topical papaverine applied to the renal hilar vessels would be the next step. A fluid bolus in the presence of increased intraperitoneal pressure from the pneumoperitoneum is usually of little to no benefit. There is no role for systemic heparinization in this patient.
- A 54-year-old man with prostate cancer has skeletal metastases. Three months after beginning LH-RH agonist therapy, his PSA is undetectable. The likelihood of developing further bone pathology is best reduced with:
- enzalutamide
- abiraterone
- bicalutamide
- estramustine
- denosumab.
5
Use of denosumab or bisphosphonate therapy in men with prostate cancer has demonstrated two outcomes: prevention of osteoporosis and reduction of skeletal-related events. Denosumab and zoledronic acid both reduce analgesic use and the time to a skeletal event compared to placebo in this setting. However, these changes do not influence survival. None of the other listed agents will prevent bone events. The use of other agents such as enzalutamide or abiraterone have been shown to increase progression-free survival after the development of castrate resistant prostate cancer, but their immediate use in the hormone-sensitive setting is unknown. Estramustine can be associated with thromboembolic events and should not be used in this setting.
- Following a snowboarding accident, a 13-year-old girl has gross hematuria and a renal injury. Eight days later, she has a persistent ileus and a low-grade fever. CT scan is shown. The next step is:
- urethral catheter placement
- ureteral stent and urethral catheter placement
- percutaneous nephrostomy
- percutaneous drain placement
- selective angiographic embolization.
2
The CT image demonstrates a great for renal laceration with extravasation of urine into the. Africa matoma. the patient’s symptoms of a low-grade fever in ileus are consistent with potential irritation from the parametric urinoma and treatment is indicated. Options for management would be retrograde stent placement, with or without concurrent urethral catheter drainage, percutaneous nephrostomy or drain placement. Retrograde stent placement for the patient with the faster return to ambulation and normal activities with less concern for infection of the perinephric hematoma. The disadvantage of place in the ureteral stent in children is the need for anesthesia replacement and removal. Specifically if there is a large amount a clot in the renal pelvis the clock make lewd a ureteral stent. in this radiograph there is no evidence of significant blood clot in the renal pelvis and the urinal it is small, therefore, percutaneous nephrostomy is not indicated. There is no significant hematoma and therefore no need for Selective embolisation. The best treatment is ureteral stent placement with concurrent drainage of bladder.
- A 52-year-old man with erectile dysfunction has a penile curvature less than 30° that developed spontaneously 18 months ago and is unresponsive to oral Vitamin E. Doppler ultrasound reveals normal bilateral cavernous arterial flow, mild venous leak, and dorsal penile plaque. The next step is:
- oral PDE-5 inhibitor
- intracavernous pharmacotherapy
- corporal plication
- plaque incision and grafting
- penile prosthesis surgery.
1
The clinical picture is consistent with Peyronie’s disease. While the criteria for surgery include the presence of a stable and mature disease of at least 12 months from onset surgical correction is not warranted given minimum degree of angulation. The process is not indicated in this patient due to the fact he is adequate blood flow to the penis. initial therapy may be best directed to improving erectile function using non-invasive oral pharmacotherapy such as PDE5
A 65-year-old man is treated with goserelin acetate and bicalutamide for a rising serum PSA following definitive XRT for Gleason 8 prostate cancer. Bone scan and CT scan are negative. In addition to the hormone therapy, he should have annual bone density scans and:
1, observation
- monthly zoledronate (Zometa)
- weekly alendronate (Fosamax)
- calcium and Vitamin D
- denosumab.
4
Osteoporosis is a recognized risk of long-term androgen ablation and has been shown to have significant clinical impact. Men started on LH-RH agonists should receive annual bone density scans and regular calcium and Vitamin 0 supplements. Treatment of osteoporosis, if it develops, may be done with bisphosphonates, but the ideal type of therapy is not proven. Prophylactic monthly zoledronate (Zometa) or denosumab are cost prohibitive agents that have been shown to prevent bone-related events only in men with documented bony metastases.
Bladder relaxation during filling is accomplished by:
- stimulation of beta-3 adrenergic receptors via the hypogastric nerve
- stimulation of alpha-1 d receptors via the hypogastric nerve
- stimulation of alpha-1 a receptors via the hypogastric nerve
- inhibition of sympathetic input from the spinal cord
- inhibition of nicotinic receptors via the pelvic nerve.
1
The accommodation of the bladder to increasing volumes of urine is primarily a passive phenomenon dependent on the intrinsic properties of the vesical smooth muscle and the quiescence of the parasympathetic efferent pathway. Stimulation of alpha-receptors do not initiate bladder relaxation. Stimulation of beta-2 and beta-3 adrenergic receptors in the detrusor muscle results in the direct relaxation of the detrusor smooth muscle. Mirabegron, a beta-3 agonist, takes advantage of this pathway to improve symptoms of overactive bladder.
- A 32-year-old man has a weak urinary stream and recurrent UTls. He has a known urethral stricture and has undergone three dilations in the past. Retrograde urethrography is shown. The next step is:
- cystoscopy
- urethral ultrasound
- VCUG
- excision and primary anastomosis
- urethroplasty with graft or flap.
3
The retrograde urethrogram (RGUG) provided in the image is an incomplete study. Two major problems exist with this image. First, the patient is not tipped far enough laterally; this can be identified by the visible obturator ring. If either or both of the obturator rings are visible, a distortion of the urethra is produced due to an improper pelvic angle and the length of the stricture will appear shorter than it actually is. Second, not enough contrast passed through the stricture to delineate its proximal extent. A repeat RGUG would most likely not reveal any additional information. A voiding urethrogram would provide an antegrade study that will allow the physician to determine the proximal extent of the urethral stricture. To perform this study, the urologist may need to pass a glide wire through the stricture followed by a 6 Fr ureteral catheter. This will allow the bladder to be filled with contrast and not dilate or destroy the stricture. The patient is subsequently asked to void and the proximal location of the stricture identified. If you can combine the VCUG with a simultaneous RGUG, a so-called up and downogram can be obtained that will delineate the length of the stricture. Cystoscopy or urethral ultrasound would not add additional information as to the extent of the stricture. Urethral ultrasound has been shown to determine the degree of spongiofibrosis yet would not add additional information over an antegrade study regarding the length of the stricture. Urethroplasty with incomplete staging information should not be performed In order to prevent unnecessary buccal mucosa harvest, and/or added operative time in the lithotomy position while a graft is unexpectedly harvested.
Renal medullary carcinoma is characterized by:
- occurrence predominately in the left kidney
- relatively indolent clinical course
- good response to cisplatin-based chemotherapy
- typically amenable to partial nephrectomy
- metastatic disease at presentation.
5
Renal medullary carcinoma was first described in 1995 and, to date, less than 100 cases have been reported in the literature. It is an extremely aggressive disease with nearly all patients presenting with metastatic disease. Mean survival IS less than SIX months and only two longterm survivors are reported in the literature. It has not been shown to respond to standard chemotherapy and/or immunotherapy regimens. Interestingly, approximately three-fourths of cases have been reported to involve the right kidney. Recent studies have reported amplification of the ABL gene and increased expression of ABL protein in the absence of BCRABL translocation characteristic of chronic myeloid leukemia. Medullary carcinoma IS more common in patients with sickle cell trait. It tends to be central and infiltrative.
A 48-year-old man undergoes partial nephrectomy for a 3 cm renal mass. His flank drain is removed on the third postoperative day. Seven days later, he has clear fluid dripping from the flank drain site. He is otherwise asymptomatic. CT scan demonstrates a 5 cm by 10 cm fluid collection adjacent to the kidney with extravasation of contrast from the collecting system. The next step is:
- observation
- urethral catheter
- percutaneous drainage of fluid collection
- percutaneous nephrostomy
- ureteral stent.
3
Urine leak following partial nephrectomy occurs in up to 15% of cases. Provided a postoperative drain is left in situ , spontaneous closure of the urinary leak occurs within 2-4 weeks. In the case of an unrecognized or delayed urinary leak, the presence of an adjacent urinoma will prevent fistula closure and predispose the patient to Infectlon/abscess formation. Percutaneous drainage of the urinoma is the preferred method used to control a unrecognized or delayed pyelocutaneous fistula. If the leak does not heal with drainage of the urinoma consideration should be given to the possibility of either ureteral/bladder obstruction or bladd’er dysfunction as a cause of the persistent fistula. In these situations, a cystoscopy with a retrograde pyelogram followed by ureteral stent and urethral catheter placement should be pursued. The concomitant urethral catheter IS used to aid healing by preventing high pressure reflux up the ureteral stent and/or to treat bladder outlet obstruction or vOiding dysfunction as an etiology for the persistent urinary fistula.
For dosimetry planning for brachytherapy, the most accurate method to estimate prostate volume by ultrasound is based on:
- planimetry
- a sphere
- an ellipse
- a prolate ellipse
- a prolate sphere.
1
Unfortunately, no prostate is the perfect sphere, ellipse, or prolate sphere, rendering calculations somewhat inaccurate. The most accurate means of volume measurement by ultrasound IS planlmetry, which allows for variation In shape. In this, the probe is mounted on stepping device and the signal marched through the gland at defined intervals, usually 3-5 mm. At each Interval, the surface area of the prostate image is obtained. Volume is ca lcu lated by multiplYing the sum of the surface areas by the stepping interval. While a prostate ellipsoid is the calculation typically used In TRUS of the prostate, it is not as accurate as planimetry. Because of ItS superior accuracy, planlmetry IS the method of choice for brachytherapy treatment planning.
A 61-year-old man has a T1c, Gleason 7 prostate cancer with a PSA of 9.1 ng/ml. He has moderate LUTS and prostate volume of 42 ml. Before any treatment decisions are made, he should undergo:
- CT scan of abdomen and pelvis
- bone scan
- urodynamics
- assessment of life expectancy
- molecular testing.
4
This patient has intermediate-risk, clinically localized prostate cancer. According to the AUA Guidelines for the management of cl inically localized prostate cancer, as a standard an assessment of the patient’s life expectancy, overall health status, and tumor characteristics should be performed prior to making any treatment decisions. Life expectancy, not patient age, is a major factor to consider In treatment selection. When life expectancy is long, localized prostate cancer can be a cause of morbidity and mortality. On the other hand when life expectancy is relatively short, competing causes for mortality reduce the chance that a man Will experience disease progression or die from prostate cancer. Imaging studies, including CT scan, bone scan , and ProstaScint scans are generally not indicated in the pretreatment evaluation of patients with clinically localized disease. This is especially true in patients with low and Intermediate risk disease because the yield is so low to preclude their usefulness. Urodynamics are not indicated. The role of molecular testing in this setting remains uncertain.
In a man who has good daytime continence following radical cystectomy and orthotopic neobladder, nocturnal incontinence is due to:
- damage to the urinary rhabdosphincter
- neobladder hypercontractility
- inadequate compliance of the neobladder
- loss of afferent input from the detrusor to the central nervous system
- damage to the inferior hypogastric nerve plexus.
4
Isolated nocturnal incontinence is commonly noted in patients who have undergone radical cystectomy and orthotopic neobladder. This is thought to be related to loss of afferent input from the detrusor to the central nervous system. Normally, the afferent input causes a reflex rise In urethral pressure during reservoir filling. This reflex is maintained following radical prostatectomy which explains why Isolated nocturnal incontinence is uncommon after this procedure. If there was damage to the rhabdosphincter, the patient would experience incontinence during the day and night, as opposed to Isolated nocturnal incontinence. This would also be the case if the neobladder had poor compliance or had contractions. While some authors have suggested that damage to the pelvic and hypogastnc plexus contnbutes to incontinence after cystectomy, this also would not cause isolated nighttime incontinence.
A 24-year-old man with a T4 complete spinal cord injury has. urinary .incontinence despite CIC and maximal anticholinergic therapy. His urodynam1 study 1.s shown. He would like to be dry. He was injected with 300 units of onabotullnumtox1nA for lower extremity spasticity one month ago. The next step is:
- increase frequency of catheterization
- immediate injection of 200 units onabotulinumtoxinA
- injection of 200 units onabotulinumtoxinA in two months
- sacral neuromodulation
- artificial urinary sphincter.
3
The urodynamic study is consistent with detrusor overactivity. This patient has failed medical therapy so the next option, if he would like to improve hiS continence, would be bladder augmentation or onabotulinumtoxinA. Pelvic floor physical therapy would not be helpful In a patient with a complete spinal cord injury. Sacral nerve stimulation does not have an FDA indication for the treatment of neurogenic bladder. Artificial unnary sphincter would be indicated for stress urinary incontinence which would be unlikely with this level of injury and was not demonstrated on the urodynamic study. Doses of onabotullnumtoxlnA should not exceed 360 units every 12 weeks. Since this patient was injected for .his spasticity last month, he would be best treated in two months and not immediately. In addition, further treatment of both his detrusor overactivity and lower extremity spasticity with onabotulinumtoxinA should be coordinated between his urologist and physiatrist to eliminate the potential for over dosage over a period of time. Regarding the treatment of neurogenic bladder with onabotulinumtoxinA, 200 units is an efficacious starting point with the dose increased to 300 units for refractory cases. Studies comparing injections of onabotylinumtoxinA into the detrusor only, compared to a combined injection, with two-thirds of the volume injected into the detrusor and one-third of the volume injected into the trigonal areas, have found that the combination Injection had better relief of symptoms, improved compliance, and no increased nsk of veslcoureteral reflux compared to detrusor-only injections.
A 43-year-old man has a 4 cm micropapillary urothelial cacinoma. th.at extensively invades the lamina propria near the bladder dome. Musculans propna 1s present and uninvolved. The next step is:
- restaging TURBT
- partial cystectomy
- neoadjuvant chemotherapy followed by radical cystectomy
- radical cystectomy
- chemotherapy.
4
T1 tumors with aggressive features (tumor size > 3 cm, micropapillary histology, and Iymphovascular invasion) have an increased risk of progression and should undergo definite cystectomy that is highly effective for early stage tumors. While intravesical BCG IS an option for the treatment of T1 bladder cancer, the high risk features of this tumor leave the patient at very high risk of relapse and progression. This IS Inappropnate given hiS young age and excellent health. Partial cystectomy is not the best choice for tumor control given the high risk of muilifocal recurrences Within the remaining bladder. Prophylactic radiotherapy and systemic chemotherapy have not been shown to reduce the risk of recurrence in individuals with T1 disease. Micropapillary urothelial carcinoma is unlikely to respond to intravesical therapies. The use of neoadJuvant chemotherapy In non-muscle invasive disease is unproven , so Immediate cystectomy is most appropriate.
Three years after radical cystectomy and orthotopic ileal neobladder, a 61-year-old man has chronic and severe diarrhea. The next step is:
- fluid restriction
- Metamucil
- loperamide
- Vitamin B12 replacement
- cholestyramine.
5
The etiology of diarrhea following urinary diversion is related to the type and amount of bowel used in the diversion. Many patients initially suffer from diarrhea after the procedure, but this usually resolves dunng the postoperative period. A small number of patients suffer chronic and bothersome diarrhea that necessitates treatment. In the case of diversions that require ileal resection of >40 cm but < 100 cm, the diarrhea is thought to be due to decreased ileal bile salt absorption that leads to increased bile salt delivery to the co lon. This in turn leads to colonic irritation and .increased bicarbonate and water secretion. This is effectively a secretory diarrhea. The Initial treatment should be decreased fat intake and initiation of cholestyramine. In contrast, diversions in which the ileocecal valve or colon is resected result in decreased bowel transit time and an osmotic diarrhea. This is best treated with oral bulking agents and loperamlde. VitamlnB12 replacement is usually indicated in patients who have had significant portions of terminal Ileum removed , but this will not impact the diarrhea. Fluid restriction is not advisable in the setting of a urinary diversion.
65-year-old woman undergoes ureteroscopic biopsy and laser ablation of a single nght m1d-ureteral tumor. Histology reveals a low grade Ta urothelial carcinoma. The next step is:
- CT urogram and urine cytology
- quarterly upper tract surveillance, urine cytology, and cystoscopy
- ureteral stent placement and BCG instillation
- nephrostomy and antegrade administration of BCG
- partial ureterectomy and Boari flap.
2
The management of upper tract urothelial carcinoma has changed significantly in the past decade as endoscopIc technologies have Improved. Many of these tumors, which previously would have been managed by open surgical excision, can now be safely managed with endoscopIc ablation: Patients With low volume, low grade, and low stage disease can be safely managed With minimally Invasive techniques. Other factors that should lead to strong consideration of minimally invasive management include renal insufficiency or other abnormalities. In this case, the patient has a single non-invasive, low grade tumor which favors a minimally invasive nephron-sparing approach. While ureterectomy would spare the involved likely adequate initial treatment of the ureteral tumor. Follow-up for these tumors must include evaluation of both the upper tract and the bladder, as there is increased risk of bladder tumors in these patients. Therefore, quarterly upper tract surveillance with imaging or ureteroscopy, cystoscopy, and urine cytology is the best surveillance strategy In this patient. BCG for high grade upper tract UC is occasionally used in patients with a solitary kidney or similar circumstances, but there is no definitive data to support a benefit. With BCG instillation might be indicated for higher grade or stage disease managed endoscopically, It Iis unnecessary in this situation.
A 73-year-old woman with high-grade muscle invasive bladder cancer in the bladder neck and dome of the bladder as well as CIS desires an orthotopic urinary diversion. The strongest relative contraindication to this type of diversion would be:
- age
- multifocal disease
- presence of CIS
- preoperative unilateral hydronephrosis
- bladder neck involvement.
5
The incidence of tumor involving the urethra in women undergoing cystectomy for bladder urothelial carcinoma is approximately 12%. The urethral recurrence rate in properly selected patients is low at less than 4%. Bladder neck tumor involvement in women, however, may be seen in approximately 22% of patients and is a risk for a urethral tumor in about half (1 2%). Preoperative involvement of the bladder neck with tumor in women is not. an absolute contraindication as long as full-thickness, intraoperative, frozen section analysIs reveals no tumor involvement of the proximal urethra (distal surgical margin). Age, tumor grade and pathological stage do not appear to be significant risk factors or contraindications to orthotopic diversion in women. CIS and multifocality also increase the risk of urethral occurrence, but not to the same degree as bladder neck involvement.
During an inguinal approach to a pediatric hernia, the ilioinguinal nerve can be separated from the cord structures by entering the:
- external oblique fascia
- cremaster
- internal spermatic fascia
- processus vaginalis
- Scarpa fascia.
2
The ilioinguinal nerve runs in the cremaster layer, and can be effectively spared by opening the cremaster and separating it from the remainder of the cord. The nerve does not have to be individually dissected.
A 32-year-old man with bilateral congenital absence of the vas deferens (CBAVD) is most likely to have:
- unilateral renal agenesis
- a brother with vasal agenesis
- hypospermatogenesis
- low semen volume
- Y chromosome microdeletion.
4
Congenital bi lateral absence of the vas deferens (CBAVO) is associated with cystic fibrosis gene mutations In 85 Yo of patients. ApproXimately 7% of brothers will have also vasal agenesis. Only 10-15% of men with CBAVO will have unilateral renal agenesis and most of these are in patients with no identifiable cystic fibrosis gene mutation. There is no association with Y microdeletions. Semen is almost always of low volume and acidic due to hypoplasia or absence of the seminal vesicles, which provide alkalinity.
A three-month-old boy with a history of incised PUVs has a febrile illness. There is difficulty passing a catheter per urethra into the bladder to obtain a urine specimen . The most likely cause is:
- urethral stricture
- residual valve leaflet
- external sphincter spasm
- bladder neck hypertrophy
- false passage from previous catheterization.
4
Consequences of PUV are detrusor hypertrophy and bladder neck hypertrophy. The outlet obstruction will result in elongation and dilation of the prostatic urethra due to the relative lack of musculature of the prostatic urethra. The hypertrophy of the bladder neck causes an upward course of the prostatic urethra and a high riding bladder neck which can make urethral catheterization difficult. During cystoscopy of such a posterior urethra, the cystoscope must be angled directly anterior In order to gain access to the bladder. All of the other options may also make catheterization difficult, but they are less likely to occur than bladder neck hypertrophy in the setting of a history of PUV.
A 37-year-old woman with recurrent stones is taking topiramate for migraine headaches. To minimize the risk of stones, the next step is:
- amiloride
- allopurinol
- potassium citrate
- calcium carbonate
- carbonic anhydrase inhibitor.
3
In this clinical scenario, the use of topiramate creates a chronic intracellular acidosis. This in turn creates a urinary milieu similar to distal renal tubular acidosis with hyperchloremic acidosIs, high urine pH , extremely low urinary citrate, and hypercalciuria. Treatment may be potassium citrate or cessation of the medication if possible. Amiloride will reduce urine calcium when used in conjunction with thiazide but is not indicated in this situation. Allopurinol is the preferred treatment for hyperuricosuria. Calcium carbonate has no role in the medical management of kidney stones. Topiramate acts as a carbonic anhydrase inhibitor and addition of a similar agent would be counterproductive.
A 34-year-old man has priapism for more than 48 hours. He continues to have a firm, indurated penis despite a corporal-glanular shunt followed by a proximal corpora spongiosum shunt. The next step is:
- penile Doppler ultrasound and corporal blood gas determination
- continuous irrigation with an alpha-adrenergic agent
- systemic baclofen
- selective embolization of cavernosal artery
- penile prosthesis.
1
Ischemic priapism presenting in a significantly delayed fashion (> 48-72 hours) may predictably fail to resolve with intracavernous treatment as well as surgical shunting and suggests that erectile dysfunction will be the inevitable outcome. Even if a successful shunt IS performed, woody induration of the penis may persist. To confirm the presence of persistent hypoxemia, a penile Doppler ultrasound to assess for vascular flow and a corporal blood gas determination should be performed. If these evaluations confirm poor vascular flow and continued Ischemia, experts have advocated immediate placement of a penile prosthesIs. The recommendation is based in part on the knowledge that placement of a penile prosthesIs at a later time, after significant fibrosis has evolved, is extremely difficult and fraught with hlghercompllcatlon rates. Based on the duration of priapism , it is unlikely that continuous Irrigation with an alphaadrenergic agent or systemic baclofen would be effective. Selective embolization of the cavernosal artery is a consideration for treatment of high flow priapism, not Ischemic Induced priapism.
A 63-year-old man has an incidentally discovered 3.8 cm left adrenal mass with a negative endocrine evaluation. The test most likely to differentiate between malignant and benign histology is:
- MRI scan
- duplex Doppler ultrasound
- CT scan with and without contrast
- MIBG
- fluorodeoxyglucose PET.
3
Lesion size is the most reliable clinical means to differentiate benign from malignant incidental adrenal tumors. Tumors < 4 cm in size are malignant in only 2% of cases. All of the listed radiographic techniques have been applied to adrenal tumor diagnosis, however, CT scan without and with contrast with measurement of contrast washout IS the most reliable indicator for malignant mass. On non-contrast images, lipid-rich adrenal adenomas will be homogenous and will have < 10 Hounsfield units. For lesions with> 10 Hounsfleld units, a washout contrasted CT scan is necessary to distinguish benign lipid-poor adenomas versus malignant masses. Malignant masses will have delayed washout of contrast maintaining an average of 30 Hounsfield units higher signal intensity at ten minutes following contrast administration when compared to benign lesions which washout rapidly.